Paul Andrew Moore, Chief Scientific Officer: Zymeworks ZYME Sell · Filed 01/12

Trade details

Type: Insider sale
Amount: $216,725.2
Shares · price: 9,560 sh · $22.67 a share
Held after: 48,497 sh
Stock: Zymeworks ZYME
Person: Paul Andrew MooreChief Scientific Officer
Trade date: 26/01/12
Filed: 26/01/12
Days to filing: 0 days

Sold 16.5% of holdings

Share of holding sold: 16.5%

Zymeworks trades, last 26 weeks

What else happened in Zymeworks around then

Filed or reported within 30 days of the trade day · 25/12/13~02/11

Paul Andrew Moore's recent trades

Paul Andrew MooreChief Scientific Officer
Planned saleZymeworks
Planned sale
Zymeworks
ZYME
$221.5K
9,560 sh
$221.5K
Filed 01/12
Traded 01/12
Paul Andrew MooreChief Scientific Officer
SellZymeworks
Sell
Zymeworks
ZYME
$271.6K
10,821 sh
$271.6K
Filed 01/05
Traded 01/05
Paul Andrew MooreChief Scientific Officer
SellZymeworks
Sell
Zymeworks
ZYME
$233.2K
9,289 sh
$233.2K
Filed 01/05
Traded 01/05
Paul Andrew MooreChief Scientific Officer
Planned saleZymeworks
Planned sale
Zymeworks
ZYME
$535.3K
20,110 sh
$535.3K
Filed 01/05
Traded 01/05
Paul Andrew MooreChief Scientific Officer
SellZymeworks
Sell
Zymeworks
ZYME
$170.2K
11,408 sh
$170.2K
Filed 25/01/06
Traded 25/01/06